Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Reporter Kim Jisun / approved : 2024-08-14 03:32:54
  • -
  • +
  • 인쇄

Seo Jung-jin, honorary chairman of Celltrion (photo= Celltrion)

 

[Alpha Biz= Reporter Kim Jisun] Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Celltrion announced on August 13 that its self-immune disorder treatment, Yuflyma (ingredient: adalimumab), is now available for purchase at Costco, a major U.S. retailer. The drug was registered with the Costco Member Prescription Program (CMPP) as of August 1 (local time).

The CMPP allows Costco members to buy medications at discounted prices from in-store or affiliated pharmacies. Starting this month, uninsured Costco members and their dependents can purchase Low WAC Yuflyma at a reduced price from Costco stores and partner pharmacies across the U.S.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

Hyundai Motor Securities Raises SK Hynix Target Price by 24.6% to KRW 405,0002025.09.17
Shinhan Investment & Securities Maintains ‘Buy’ Rating on Orion, Expects Sales Growth and Stock Recovery in Second Half2025.09.17
Samsung Securities Raises Target Price for L&F to KRW 100,000, Citing Stronger Fundamental Recovery2025.09.17
Hyundai Mobis Union Continues Strike Independently, Citing Broken Wage Agreement2025.09.17
Over KRW 1.5 Trillion in Pension Premiums Miscollected Over Past 5.5 Years2025.09.17
뉴스댓글 >